Swift Biosciences' Series B - II Round

Swift Biosciences raised a round of funding on September 10, 2015.

Swift Biosciences is focused on developing innovative enabling technologies for genomics and personalized medicine. With the launch of its line of Accel-NGS products, Swift is now applying its unique …

Articles about Swift Biosciences' Series B - II Round: